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Type VII collagen is the major component of anchoring
fibrils, adhesion structures of stratified epithelia that span
the basement membrane region and papillary dermis.
Mutations in the gene COL7A1 encoding type VII colla-
gen cause dystrophic epidermolysis bullosa, a clinically
heterogeneous autosomal dominant or recessive blis-
tering disorder of the skin and mucous membranes. In
this report, we investigate three siblings affected by an
unusually mild form of localized recessive dystrophic
epidermolysis bullosa who were shown to be compound
heterozygotes for novel mutations affecting COL7A1.
The maternally inherited mutation is a G→C transversion
that converts a codon for glycine to a codon for arginine
(G1347R). The paternal mutation is a neutral G→A
transition at the last base of exon 70 (5820G→A) that
alters the correct splicing of COL7A1 pre-mRNA, giving
rise to an aberrant mRNA carrying the in-frame skipping
of exon 70 in addition to the full-length RNA transcript
Dystrophic epidermolysis bullosa (DEB) is a clinicallyheterogeneous group of autosomal dominant or recess-ive bullous disorders of the skin and mucous membranescharacterized by blister formation consequent to vary-ing degrees of trauma, healing with scarring, and nail
dystrophy (Fine et al, 1991; Zambruno et al, 1998). The hallmark of
DEB is the localization of the blister cleavage plane below the basement
membrane zone (BMZ) at the level of the anchoring fibrils (Fine et al,
1991; Zambruno et al, 1998). The latter are attachment structures of
stratified epithelia that connect the BMZ lamina densa to the upper
dermis and are mainly composed of type VII collagen, a nonfibrillar
collagen derived from the assembly of three pro-α1(VII) chains each
containing a central collagenous domain flanked by two noncollagenous
regions (Burgeson, 1993). The clinical heterogeneity of DEB is
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carrying the G→A substitution. Consistent with the nor-
mal levels of COL7A1 mRNA transcripts detected by
northern analysis, immunoblotting and immunofluores-
cence studies evidenced that the patient keratinocytes
synthesize and secrete normal amounts of stable type VII
collagen, which is correctly deposited at the dermal–
epidermal junction. In addition, mutated type VII colla-
gen molecules assemble to form numerous, normally
shaped anchoring fibrils, as shown by electron micro-
scopic examination. The combination of a recessive
glycine substitution with a splice site mutation that
permits partially correct splicing therefore leads to a
normal expression of mutated type VII collagen molec-
ules with marginally altered biologic activity, and to the
extremely mild phenotype observed in our patients.
Key words: anchoring fibrils/inherited blistering skin diseases/
molecular genetics/type VII collagen. J Invest Dermatol 111:744–
750, 1998
underscored by various biologic alterations in the anchoring fibrils,
such as abnormalities in shape and number and a decreased/absent
immunoreactivity for type VII collagen (Bruckner-Tuderman et al,
1989, 1995; McGrath et al, 1993; Ko¨nig et al, 1994), which, in turn,
result from a range of mutations in type VII collagen gene (COL7A1)
(Hovnanian et al, 1997; references herein).
In dominant DEB all mutations identified to date cause glycine
Figure 1. Pedigree of the localized RDEB family. The segregation of the
glycine substitution G1347R (half black symbols) and the splice site mutation
5820G→A (half gray symbols) is shown.
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Figure 2. Clinical, ultrastructural, and
immunofluorescence features of the
localized RDEB family. Patient II.3 exhibits
several small blisters, erosions, crusts, and scars
on the hand palmar (A) and, to a lesser extent,
dorsal (B) surfaces; mild dystrophy of fingernails
is also present (B). Electron microscopy of the
dermal–epidermal junction (DEJ) of uninvolved
RDEB skin (C) reveals the presence of
numerous, cross-banded anchoring fibrils
(arrows), which appear similar to those detected
in normal control skin (D) (k, basal keratinocyte,
d, dermis; asterisk, lamina densa). By
immunofluorescence microscopy, the linear
labeling of the DEJ with monoclonal antibody
LH7:2 against collagen VII is similar in control
(F) and RDEB skin (E), where it is localized
along the roof of an initial blister (asterisk). Scale
bars: (C, D) 0.5 µm; (E) 16 µm; (F) 20 µm.
substitutions within the triple helix of type VII collagen, which are
considered to exert a dominant negative effect by altering the folding
of the collagen chains (Christiano et al, 1994a, 1996a, b; Lee et al,
1997; Winberg et al, 1997). In contrast, mutational events in the
recessive DEB (RDEB) phenotypes vary considerably (Hovnanian et al,
1997 and references therein; Christiano et al, 1996b; Tamai et al, 1997;
Winberg et al, 1997). In Hallopeau-Siemens disease, the genetic
mutations often cause premature termination codons that inactivate the
expression of the two COL7A1 alleles through premature termination
codon-mediated mRNA decay and result in the absence of type VII
collagen and anchoring fibrils (Hovnanian et al, 1997 and references
therein). In the generalized forms of RDEB, at least one other
molecular mechanism has been pointed out that involves recessive
missense mutations resulting in the synthesis of type VII collagen with
decreased stability and/or altered function (Hovnanian et al, 1997 and
references therein). Finally, two splicing mutations, one of which
permits some correct splicing of COL7A1 pre-mRNA, have been
identified in the only patient with the localized form of RDEB so far
characterized (Gardella et al, 1996).
We report three siblings affected by an unusually mild form of
localized RDEB who are compound heterozygotes for a recessive
glycine substitution and a splice site mutation. Analysis of the mutation
consequences demonstrated that normal steady state levels of COL7A1
mRNA are present in the patient keratinocytes leading to the secretion
of stable type VII collagen molecules that form morphologically typical
anchoring fibrils. The combined data provide evidence that normal
expression of mutated type VII collagen molecules with marginally
altered biologic activity are responsible for the extremely mild pheno-
type found.
MATERIALS AND METHODS
Patient data Complete clinical examination of all family members was carried
out by two of the authors (G.S., G.Z.). Skin biopsies were obtained from
patient II.3 (Fig 1), the patient’s mother, and healthy controls and processed for
immunofluorescence and electron microscopy studies, and keratinocyte cultures.
Electron microscopy studies Skin biopsy specimens were fixed in 2%
glutaraldehyde, post-fixed in 1% osmium tetroxide, dehydrated in graded
alcohols, embedded in Epon resin, and then sectioned on a Reichert Ultracut
E ultramicrotome. Ultrathin sections were stained with uranyl acetate and lead
citrate and observed in a Philips CM100 transmission electron microscope
(Eindhoven, The Netherlands).
Immunofluorescence analysis Frozen 5 µm thick skin sections were
processed for immunofluorescence using a three-step biotin-streptavidin-
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Figure 3. Northern blot and immunoblot analysis of collagen VII
mRNA and protein levels in localized RDEB keratinocyte cultures. (A)
Northern blot analysis of total RNA shows a signal of similar intensity for the
collagen VII probe in patient II.3 (lane 1) and control keratinocytes (lane 2);
GAPDH, glyceraldehyde-3-phosphate dehydrogenase probe used for loading
control. (B) Cell extracts were subjected to sodium dodecyl sulfate-
polyacrylamide gel electrophoresis under denaturing conditions followed by
immunoblotting with antibodies to collagen VII. Control keratinocyte extracts
revealed a strong band of procollagen VII (white arrowhead; lane 1), similarly to
extracts of proband II.3 (lane 2), the mother I.2 (lane 3), and a healthy unrelated
control (lane 4). The keratinocyte extracts were subjected to limited pepsin
treatment, and the digestion products were reacted with antibodies recognizing
the triple-helical and the carboxy-terminal NC-2 domains of procollagen VII.
The digestion removed the globular domains of procollagen VII and resulted
in the appearance of three bands on the immunoblots: the intact triple helical
domain and its amino-terminal half, the P2 fragment, as well as its carboxy-
terminal half, the P1 fragment (black arrowheads, from top to bottom,
respectively). In the extracts of probands II.3 (lane 6), the mother I.2 (lane 7),
and a healthy unrelated control (lane 8), bands of similar intensity were observed,
indicating that the mutations did not result in significant destabilization of
collagen VII triple-helix. The 17 amino acid deletion caused by the splice site
mutation in exon 70 is located amino-terminally adjacent to the COL7A1
central hinge region, the main pepsin cleavage site that generates the P1 and
P2 fragments. The glycine substitution G1347R resides well within the long
triple helical fragment P2, more than 90 amino acid residues from the putative
amino-terminal pepsin cleavage site of this fragment. Lane 5 shows molecular
weight standards, from top to bottom: 200, 120, 80, and 50 kDa.
fluorescein procedure, as described (Kanitakis et al, 1989). Expression of
collagen VII was evaluated using monoclonal antibody (MoAb) LH7:2 (Cymbus
Bioscience, Southampton, U.K.). Immunomapping of the epidermal basement
membrane components was performed using the anti-laminin 5 MoAb GB3
(gift from G. Meneguzzi, INSERM U385, Nice, France) (Verrando et al, 1991);
MoAb G0H3, directed against the α6 integrin subunit (gift from A. Sonnenberg,
the Netherland Cancer Institute, Amsterdam, The Netherlands) (Sonnenberg
et al, 1987); the anti-β4 integrin subunit MoAb 3E1 (Telios, San Diego, CA);
MoAb HD121 and 1A8C, recognizing the hemidesmosomal proteins HD1 and
BP180 (180 kDa bullous pemphigoid antigen, BPAG2), respectively (gift from
K. Owaribe, Nagoya University, Nagoya, Japan) (Owaribe et al, 1991). The
rabbit anti-serum to type IV collagen was purchased from Institut Pasteur
(Lyon, France). The following sera and detection systems were employed:
biotinylated horse anti-mouse IgG serum (Vector Laboratories, Burlingame,
CA), biotinylated rabbit anti-rat IgG serum (Vector Laboratories), biotinylated
goat anti-rabbit IgG serum (Vector Laboratories), and fluorescein-streptavidin
(Amersham International, Little Chalfont, U.K.).
Keratinocyte cultures Human epidermal keratinocytes were cultivated on
a feeder-layer of lethally irradiated 3T3-J2 murine fibroblasts (a gift from
H. Green, Harvard Medical School, Boston, MA), as described (Zambruno
et al, 1995).
Northern analysis For each sample, 20 µg of total RNA was separated by
electrophoresis through a 1% agarose/formaldehyde gel, and transferred to
Hybond-N1 nylon membrane in 203sodium citrate/chloride buffer, as devised
by the supplier (Amersham International). To detect the collagen VII transcripts,
membranes were hybridized with a 32P-labeled 523 bp collagen VII cDNA
probe generated by reverse transcriptase-polymerase chain reaction (RT-PCR)
and spanning the NC-1 domain of COL7A1 from nt 734 to nt 1256. For
loading control, membranes were hybridized with a probe corresponding to
the ubiquitously expressed glyceraldehyde-3-phosphate dehydrogenase gene.
Quantitation of autoradiograms was performed by densitometric scanning using
a GS-750 densitometer (Biorad, Hercules, CA).
Protein extraction and immunoblot analyses The proteins of keratinocyte
cultures were extracted with a neutral buffer containing 0.1 M NaCl, 0.020 M
Tris-HCl, pH 7.4, 1% NP-40, and a mixture of proteinase inhibitors (Sonnenberg
et al, 1991). The stability of procollagen VII in the extracts was analyzed by
limited pepsin digestion. For that purpose, cell extracts were acidified with
glacial acetic acid to a final concentration of 0.1 M, and the samples were
incubated with 10 µg pepsin (Fluka, Deisenhofen, Germany) per ml for 2 h at
5°C. After neutralization with 0.5 M HEPES, pH 8.0, the samples were
precipitated with ethanol and subjected to immunoblotting with antibodies to
the triple helical and the carboxy-terminal (NC-2) domain of human collagen
VII as described (Bruckner-Tuderman et al, 1995).
Mutation detection Genomic DNA, extracted from peripheral blood of the
probands, the parents, and the controls was used as a template for amplification
of individual exons of COL7A1 gene, as described (Christiano et al, 1997).
Specifically, to amplify a 445 bp region of COL7A1 comprising exons 34–
35, primers were (L) 59 TGCTCTCTAAGTGTCTTCCC 39 and (R) 59
CCCACTACACATCACTTGCC 39. Primers used for amplification of a
433 bp portion of COL7A1 gene containing exons 69–70, were (L) 59
TGAGTGCGGATGTTGGGTAG 39 and (R) 59 GCCCAAGTTCCCTTGA-
GTGT 39 (Christiano et al, 1997). For polymerase chain reaction (PCR)
amplification, 100 ng of genomic DNA was used as template in 50 µl of
reaction mixture containing 10 mM Tris-HCl pH 8.3, 50 mM KCl, 1.5 mM
MgCl2, 50 pmol of each primer, 20 µmol of each deoxynucleotide, and 2.0 U
of AmpliTaq Gold polymerase (Perkin Elmer, Roche Molecular Systems,
Branchburg, NJ). PCR conditions were 94°C for 10 min; followed by 94°C
for 30 s, Tm of primers for 30 s, and 72°C for 30 s (35 cycles). PCR
amplification products were subjected to heteroduplex analysis by conformation-
sensitive gel electrophoresis (Ganguly et al, 1993). If a heteroduplex band was
detected, the PCR product was subjected to direct sequencing by Thermo
Sequenase 33P-radiolabeled terminator cycle method (Amersham International).
Mutation verification Allele-specific oligonucleotide (ASO) analysis was
carried out to verify the exon 34 mutation and to assess its inheritance in
the kindred, as described (Ruzzi et al, 1997). The ASO used were 59
TACCGGCTCCCCCTTTGG 39 for the wild-type allele, and 59
TACCGGCTCCCGCTTTGG 39 for the mutated allele. To verify the exon
70 mutation at the genomic level, aliquots of the corresponding amplification
product were subjected to digestion with the restriction enzyme HphI (New
England Biolabs, Beverly, MA).
RT-PCR Because the exon 70 mutation occured at position –1 of the 59
splicing site of intron 70, we looked for the presence of altered transcripts by RT-
PCR. Approximately 2.5 µg of total RNA isolated from cultured keratinocytes
(Chomczynski and Sacchi, 1987) were reverse-transcribed in a volume of 20 µl
using SuperScript RNase H free reverse transcriptase (Gibco BRL, Gaithersburg,
MD). PCR amplifications were performed using 1 µl of cDNA in a reaction
volume of 25 µl. The oligonucleotides used were (L) 59 GTTTTCCTGGTGT-
CCCAG 39 (nt 5702–5719) and (R) 59 AGGCAGGAAGCTACCAGA 39 (nt
5699–5916) (GenBank accession # L02870). Aliquots of the amplified products
were analyzed on 3% agarose gel electrophoresis, subcloned into the pCR
2.1 TA vector (Invitrogen, San Diego, CA), and sequenced by standard
dideoxynucleotide techniques (Sanger et al, 1977) using the Sequenase version
2.0 DNA Sequencing Kit (Amersham International). To estimate the relative
initial amount of the two fragments identified, a PCR kinetic analysis was
carried out as described (Salomon et al, 1992; Pie´ et al, 1997), with minor
modifications. PCR amplification of cDNA was performed for different numbers
of cycles (25–40) and aliquots of the amplification products were analyzed on
3% agarose gel electrophoresis. The gel was then blotted on a Hybond-N1
nylon membrane according to the alkaline blotting procedure (Amersham
International) and hybridized with a reverse γ32P-labeled oligonucleotide 59
GCAGTTTCCAGCAACCGATC 39 spanning exon 71 (nt 5827–5846). In
each lane, the peak areas of both cDNA bands were measured by densitometric
scanning of autoradiograms and plotted as log area values versus the cycle
number. Semi-logarithmic plots resulted in two straight lines with identical
slopes over the range of 30–40 cycles, indicating a similar amplification efficiency
of both fragments. To determine the relative difference in the initial amount
of the two mRNA transcripts, the log area value was extrapolated to the
intercept for each line.
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Figure 4. Identification of the heterozygous missense mutation G1347R in COL7A1 gene of patient II.3 and inheritance in the kindred. (A) Total
genomic DNA was subjected to PCR reaction using primers which amplify a 445 bp fragment spanning exons 34–35 of COL7A1. In comparison with the DNA
of a normal control, sequencing of the patient’s DNA reveals a G→C transversion at nucleotide position 4039 of exon 34 that changes a glycine codon to an
arginine codon at amino acid residue 1347. The mutation is designated G1347R. (B) ASO analysis: hybridization of the 445 bp PCR product with a wild type
(WT) and mutated (M) ASO shows the heterozygous state of the mutation in the three affected siblings (II.2, II.3, II.5), the patients’ mother (I.2), and a healthy
member (II.1) of the kindred. C, unaffected control individual.
RESULTS
Members of a family affected with an extremely mild form of
localized RDEB display normal type VII collagen immunoreac-
tivity and anchoring fibril morphology in the skin The patients
were three Italian siblings (Fig 1, II.2, II.3, and II.5) aged 30, 28, and
27, respectively, born of nonconsanguineous and clinically unaffected
parents. Two other siblings (Fig 1, II.1 and II.7) were unaffected and
there was no family history of skin or genetic diseases. All the probands
had been suffering from skin blisters and erosions since their first
month of life. During early childhood, lesions were strictly localized
on trauma-exposed sites, i.e., elbows, knees, hands, and feet, whereas,
from early adulthood onwards, they appeared exclusively on the palmar
and dorsal surfaces of hands (Fig 2A, B) and, to a lesser extent, feet.
The lesions resolved with mild scarring and milia formation (Fig 2A,
B). On examination, dystrophy of fingernails (Fig 2B) and toenails
was also observed, whereas mucosae, hair, and teeth showed no lesions.
The diagnosis of DEB was confirmed by ultrastructural examination
of a skin biopsy from patient II.3, which localized the cleavage plane
below the lamina densa of the cutaneous BMZ (not shown). In
noninvolved skin, the numerous anchoring fibrils present along the
BMZ appeared of normal length and thickness, and revealed a well-
defined cross-banding pattern (Fig 2C, D). Other components of the
cutaneous BMZ, including hemidesmosomes and anchoring filaments,
exhibited no significant abnormalities.
Antigen mapping was performed by immunofluorescence staining
of frozen skin sections using antibodies recognizing the major compon-
ents of the cutaneous BMZ. In areas of microblistering, the staining
for the hemidesmosomal components α6β4 integrin, BP180 (180 kDa
bullous pemphigoid antigen, BPAG2), and plectin, as well as that for
laminin 5 and type IV and VII collagens, was localized to the blister
roof, indicating that tissue separation occurs below the lamina densa
at the level of the anchoring fibrils, and confirming the diagnosis of
DEB (not shown). Type VII collagen exhibited a strong, linear labeling
along the BMZ, with an intensity comparable with that observed in
normal control skin (Fig 2E, F).
Collagen VII mRNA and protein levels are similar in localized
RDEB and control keratinocytes The level of expression of the
gene for type VII collagen was assessed by northern analysis of total
RNA obtained from cultured keratinocytes of patient II.3, the patient’s
mother, and a healthy control. Densitometric analysis of the hybridiza-
tion bands did not reveal any significant reduction of the steady state
level of collagen VII mRNA in the patient as compared with the
control (Fig 3A).
Consistent with these results, immunoblotting analysis of cultured
keratinocytes from patient II.3, the mother, and normal controls
showed that comparable amounts of collagen VII could be extracted
from all the cell cultures (Fig 3B). A pepsin digestion under mild
conditions resulted in fragmentation of collagen VII into the triple
helix and the P1 and P2 fragments in all three extracts (Burgeson,
1993). The relative intensity and stability of the fragments were similar
(Fig 3B), implying that the genetic defects do not lead to significant
destabilization or intracellular accumulation of collagen VII in the
RDEB keratinocytes.
Mutation analysis reveals compound heterozygosity for a recess-
ive glycine substitution and a splice site mutation in COL7A1
gene The entire COL7A1 gene was scanned by PCR amplification
of individual exons and flanking intronic boundaries, followed by
heteroduplex analysis of the PCR products using conformation-
sensitive gel electrophoresis. Conformation-sensitive gel electrophoresis
analysis of genomic DNA from patient II.3 showed two distinct shifts,
corresponding to exons 34–35 and 69–70. Direct sequence analysis of
the PCR product corresponding to exons 34–35 (445 bp) detected a
G→C transversion at nucleotide position 4039 (4039G→C) of exon
34 that changes a glycine codon to an arginine codon at amino acid
residue 1347 (GenBank, accession #L02870) (Fig 4A). The mutation
was therefore designated G1347R. ASO analysis confirmed the hetero-
zygous state of mutation G1347R in the three affected siblings and in
a healthy member of the kindred, and demonstrated the maternal
inheritance (Fig 4B). Screening 150 alleles from unrelated, healthy
individuals by ASO analysis failed to disclose the presence of muta-
tion G1347R.
Direct sequencing of the 433 PCR product corresponding to exons
69–70 and the flanking intronic regions detected a neutral G→A
substitution at nucleotide position 5820 of the 59 donor splice site of
intron 70 (Fig 5A). Mutation 5820G→A abolishes a restriction site
for endonuclease HphI. Digestion of the PCR product with this
enzyme revealed that the three affected siblings, their father, and two
unaffected family members were heterozygous for the mutation,
whereas the mother did not demonstrate this genetic lesion (Fig 5B).
In addition, mutation 5820G→A was not present in 150 alleles from
unrelated healthy individuals, confirming that this substitution does
not represent a common polymorphism.
The splice site mutation results in an aberrant mRNA carrying
the in-frame skipping of exon 70 and a full-length transcript
carrying the G→A substitution The mutation 5820G→A occurs
at position –1 of the 59 donor splice site of intron 70. Because in
primates 78% of genes harbor a G in this position, an aberrant splicing
could be expected (Shapiro and Senapathy, 1987). To verify this
possibility, mRNA obtained from cultured keratinocytes of patient II.3
was analyzed by RT-PCR using primers that amplify nucleotides 5702–
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Figure 5. Identification of the heterozygous splice site mutation
5820G→A in COL7A1 gene of patient II.3 and inheritance in the
kindred. (A) Total genomic DNA was subjected to PCR reaction using
primers that amplify a 433 bp fragment encompassing COL7A1 exons 69–70.
As compared with the DNA of a normal control, sequencing of the patient’s
DNA reveals a G→A substitution at the last nucleotide of exon 70 (nt position
5820). The mutation is designated 5820G→A. (B) Verification of mutation
5820G→A with HphI restriction endonuclease digestion of the 433 bp PCR
product. Five fragments (a 150 bp doublet, and 58, 40, 35 bp bands) are visible
in the mother and an healthy unrelated control (C), and an additional 300 bp
fragment (from the 150 bp doublet) is detected in the three affected siblings
(II.2, II.3, II.5), their father (I.1), and two healthy family members (III.1, III.2),
which is indicative of a heterozygous state for mutation 5820G→A. The
markers for molecular size (100 bp DNA ladder, from 2000 to 100 bp) are in
lane M. (C) Schematic representation of the localization of HphI sites within
the 433 bp amplified fragment, an arrow denotes the site abolished by mutation
5820G→A.
5916 of COL7A1 cDNA. Analysis of the amplification product on
3% agarose gel revealed a clearly detectable, fast-migrating DNA
fragment, in addition to the expected 215 bp band (Fig 6A). Isolation,
subcloning, and sequencing of the 215 bp cDNA band identified
transcripts corresponding to a correctly spliced mRNA. Four of 32
independent clones carried mutation 5820G→A (Fig 6B). Sequencing
of cDNA clones derived from the fast-migrating band identified an
abnormal mRNA transcript originating from the in-frame skipping of
the entire exon 70 (48 bp) (Fig 6B). In addition, the ratio between
the mRNA species carrying the in-frame exon skipping and the full-
length mRNA transcripts obtained by PCR kinetic analysis was 1:1.45
(see Materials and Methods, Fig 6A), indicating that the internally
deleted mRNA represents 40.8% of the total collagen VII mRNA.
DISCUSSION
In this report, we describe the molecular defect in three siblings
suffering from an extremely mild form of localized RDEB. A search
Figure 6. RT-PCR and cloning analysis of the effects of splice site
mutation 5820G→A at the mRNA level. (A) The mRNA from cultured
keratinocytes was analyzed by RT-PCR using oligonucleotide primers that
amplify nt 5702–5916 of COL7A1 cDNA. In addition to the expected major
215 bp band present in the controls (C1, C2, C3), analysis of the amplification
product reveals a smaller band in patient II.3. The inset shows the electrophoretic
pattern of the two amplified bands in relation to the number of PCR cycles.
The markers for molecular size (100 bp DNA ladder, from 2000 to 100 bp)
are in lane M. (B) As compared with a normal control, sequence analysis of a
clone obtained from the 215 bp band (mutant cDNA 1) reveals a G→A
substitution at the last nucleotide of exon 70. Isolation and cloning of the
smaller band reveals an aberrant mRNA bearing an in-frame skipping of the
entire exon 70 (48 bp) (mutant cDNA 2).
for mutations in the COL7A1 gene demonstrated that the probands
are compound heterozygotes for two novel mutations, the glycine
substitution G1347R and the splice site mutation 5820G→A, which
further extend the molecular heterogeneity of DEB.
The maternally inherited G→C transversion in exon 34 results in
substitution G1347R within the second of the 20 collagenous subdo-
mains that form the collagen VII triple helix (Christiano et al, 1994b).
Substitution G1347R results in a recessively inherited condition,
because two healthy family members were heterozygous carriers of the
mutation. To date, several recessively inherited missense mutations,
mainly glycine substitutions, within the triple helix of the COL7A1
gene have been described in the Hallopeau-Siemens and mitis variants
of generalized RDEB (Hovnanian et al, 1997 and references therein;
Christiano et al, 1996a). Because heterozygous carriers are unaffected,
these mutations are expected to act through mechanisms distinct from
the dominant negative effect of other glycine substitutions reported in
dominant DEB (Christiano et al, 1994a, 1996a, b; Lee et al, 1997;
Winberg et al, 1997).
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This study reports that a recessively inherited glycine substitution
combined with a splice site mutation in trans results in a localized
variant of RDEB. In our patient, the steady state level of type VII
collagen mRNA comparable with normal controls is in agreement
with similar data reported in other recessively inherited COL7A1
missense mutations and with the observation that missense mutations
do not usually alter RNA stability (Hovnanian et al, 1997). Immunoblot-
ting and immunofluorescence analysis show type VII collagen levels
similar to healthy controls, and ultrastructural observation reveals
numerous, well-formed anchoring fibrils. These findings suggest that
mutation G1347R not only allows synthesis, secretion, and deposition
of stable collagen VII molecules, but also does not significantly interfere
with the supramolecular assembly of collagen VII into anchoring fibrils.
The paternal mutation is a neutral G→A transition at position –1
of the donor splice site (5820G→A) of intron 70. In this study, we
show that mutation 5820G→A alters the correct splicing of COL7A1
pre-mRNA and generates a mRNA bearing a deletion of 48 nucleotides
(transcript 2), and a full-length transcript carrying the G→A substitution
(transcript 1). Transcript 2 carries an in-frame skipping of exon 70 and
codes for a type VII collagen polypeptide with an internal deletion of
16 amino acids spanning the last 5 Gly V-X-Y repeat sequences of the
tenth collagenous subdomain of the triple helix and the first of the 39
amino acids that form the nonhelical stretch located in the middle of
the helix (Christiano et al, 1994b). Although transcript 2 accounts for
about 40% of the total COL7A1 mRNA and therefore represents the
majority of the mRNA species produced from the paternal allele,
minute amounts of correctly spliced RNA transcript 1 were also
detected. In our patient, the normal steady state levels of COL7A1
mRNA detected by northern analysis clearly indicate that, in addition
to transcript 1, the far more abundant paternal transcript 2 carrying
the in-frame skipping of exon 70 is also not degraded and contributes
to the normal expression of collagen VII.
It has been shown that, in several genes, splice site mutations that
permit some correct splicing lead to mild phenotypic disease variants
(Weil et al, 1989; Akli et al, 1990; Aslanidis et al, 1996; Gardella et al,
1996; Posteraro et al, 1998). Interestingly, the only other case of
localized RDEB characterized to date results from the combination of
two splice site mutations, one of which affects position –1 of the donor
splice site of intron 95 and causes partial correct splicing of the mutant
COL7A1 pre-mRNA (Gardella et al, 1996). Mutational analysis of
additional patients is required to determine whether splice site mutations
allowing some correct splicing represent a common mechanism in
localized forms of RDEB.
In conclusion, our results indicate that both the maternal transcript
carrying the recessive glycine substitution and the paternal aberrant
transcripts 1 and 2 encode the stable collagen VII polypeptides visualized
by immunofluorescence and immunoblotting. The subsequent supra-
molecular assembly of mutated collagen VII molecules into apparently
normal anchoring fibrils with a marginal functional defect explains the
extremely mild and localized phenotype in the probands who develop
blistering lesions exclusively at sites of major, repeated traumatisms.
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